Evolent Health Stock Fair Value – Peregrine Capital Management LLC Reduces Stake in Evolent Health by 7.1% in Q1
July 14, 2023
🌥️Trending News
Evolent Health ($NYSE:EVH), Inc. is a healthcare company that provides population health management services to organizations across the country. It works with health systems and payers, including managed care organizations, government agencies, and other health service providers. The fund is run by a team of experienced hedge fund managers who employ a variety of strategies in order to generate returns for their investors. This reduction in ownership could be a sign that the fund is looking to reduce exposure to the healthcare sector, as Evolent Health has been a major contributor to its returns since its initial public offering. Despite the reduction in ownership, Evolent Health still remains a strong company and has seen steady growth over the past few years.
Its products and services are aimed at providing population health management services to help organizations maximize their investments in healthcare. The company has also been making strides in technology, launching its own app and artificial intelligence platform to further enhance its offering. Overall, Peregrine Capital Management LLC’s reduction in ownership of Evolent Health could be a sign of hedging against potential future losses due to the unpredictability of the healthcare sector. While this is merely speculation, it serves as a reminder that investors should be mindful of the risks associated with investing in any company, regardless of its size or sector.
Analysis – Evolent Health Stock Fair Value
At GoodWhale, we have conducted an analysis of EVOLENT HEALTH‘s wellbeing. From our proprietary Valuation Line, we have determined the intrinsic value of an EVOLENT HEALTH share to be approximately $27.4. At the moment, EVOLENT HEALTH is trading at $28.6, which makes it fairly overvalued by 4.4%. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Evolent Health. More…
Total Revenues | Net Income | Net Margin |
1.48k | -40.07 | -2.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Evolent Health. More…
Operations | Investing | Financing |
37.91 | -670.87 | 562.65 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Evolent Health. More…
Total Assets | Total Liabilities | Book Value Per Share |
2.59k | 1.47k | 7.63 |
Key Ratios Snapshot
Some of the financial key ratios for Evolent Health are shown below. More…
3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
18.3% | – | -8.1% |
FCF Margin | ROE | ROA |
0.5% | -8.7% | -2.9% |
Peers
The company’s products and services enable healthcare providers to receive and process payments from patients and third-party payers. Evolent Health Inc’s competitors include PreAxia Health Care Payment Systems Inc, Livecare Inc, PT Bundamedik Tbk, and other healthcare payment processing companies.
– PreAxia Health Care Payment Systems Inc ($OTCPK:PAXH)
PreAxia Health Care Payment Systems Inc is a healthcare technology company that provides solutions to healthcare organizations and payers. Its products and services include claims processing, payment processing, and data management. The company was founded in 1997 and is headquartered in Boston, Massachusetts.
– Livecare Inc ($OTCPK:LVCE)
The companyPT Bundamedik Tbk is a leading healthcare provider in Indonesia. The company has a market cap of 4.73T as of 2022 and a ROE of 10.69%. The company is focused on providing quality healthcare services to the Indonesian people. The company has a strong presence in the Indonesian healthcare market and is committed to providing the best possible care to its patients.
Summary
Evolent Health, Inc. is a health care delivery and payment company with a focus on value-based care. Despite the recent drop in ownership, the company has seen positive returns over the past year, showing potential for future growth. Investors should continue to monitor the company’s performance and continue to conduct their own research and analysis before investing.
Recent Posts